<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38138102</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>11</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>Long COVID or Post-COVID-19 Condition: Past, Present and Future Research Directions.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2959</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms11122959</ELocationID><Abstract><AbstractText>The presence of symptoms after an acute SARS-CoV-2 infection (long-COVID) has become a worldwide healthcare emergency but remains underestimated and undertreated due to a lack of recognition of the condition and knowledge of the underlying mechanisms. In fact, the prevalence of post-COVID symptoms ranges from 50% during the first months after the infection up to 20% two-years after. This perspective review aimed to map the existing literature on post-COVID symptoms and to identify gaps in the literature to guide the global effort toward an improved understanding of long-COVID and suggest future research directions. There is a plethora of symptomatology that can be due to COVID-19; however, today, there is no clear classification and definition of this condition, termed long-COVID or post-COVID-19 condition. The heterogeneity in the symptomatology has led to the presence of groups/clusters of patients, which could exhibit different risk factors and different mechanisms. Viral persistence, long-lasting inflammation, immune dysregulation, autoimmune reactions, reactivation of latent infections, endothelial dysfunction and alteration in gut microbiota have been proposed as potential mechanisms explaining the complexity of long-COVID. In such an equation, viral biology (e.g., re-infections, SARS-CoV-2 variants), host biology (e.g., genetics, epigenetics) and external factors (e.g., vaccination) should be also considered. These various factors will be discussed in the current perspective review and future directions suggested.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-de-Las-Pe&#xf1;as</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3772-9690</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos, 28922 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), Center for Sensory-Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raveendran</LastName><ForeName>Arkiath Veettil</ForeName><Initials>AV</Initials><Identifier Source="ORCID">0000-0003-3051-7505</Identifier><AffiliationInfo><Affiliation>Govt. Medical College, Kozhikode 676121, Kerala, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giordano</LastName><ForeName>Rocco</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1331-129X</Identifier><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), Center for Sensory-Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arendt-Nielsen</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), Center for Sensory-Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Gastroenterology, Mech-Sense, Aalborg University Hospital, DK-9000 Aalborg, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Steno Diabetes Center North Denmark, Clinical Institute, Aalborg University Hospital, DK-9000 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">genetics</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">mechanisms</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword><Keyword MajorTopicYN="N">reinfections</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38138102</ArticleId><ArticleId IdType="pmc">PMC10745830</ArticleId><ArticleId IdType="doi">10.3390/microorganisms11122959</ArticleId><ArticleId IdType="pii">microorganisms11122959</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard. 2023.  [(accessed on 1st October 2023)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>COVID-19 Treatment Guidelines.  [(accessed on 15 September 2023)]; Available online:  https://www.covid19treatmentguidelines.nih.gov/management/clinical-management-of-adults/hospitalized-adults--therapeutic-management/</Citation></Reference><Reference><Citation>Therapeutic Management of Non-Hospitalized Adults with COVID-19.  [(accessed on 15 September 2023)]; Available online:  https://www.covid19treatmentguidelines.nih.gov/management/clinical-management-of-adults/nonhospitalized-adults--therapeutic-management/</Citation></Reference><Reference><Citation>Zheng C., Shao W., Chen X., Zhang B., Wang G., Zhang W. Real-world effectiveness of COVID-19 vaccines: A literature review and meta-analysis. Int. J. Infect. Dis. 2022;114:252&#x2013;260. doi: 10.1016/j.ijid.2021.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.11.009</ArticleId><ArticleId IdType="pmc">PMC8595975</ArticleId><ArticleId IdType="pubmed">34800687</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Wang L., Li M., Xie B., He L., Wang M., Zhang R., Hou N., Zhang Y., Jia F. Real-word effectiveness of Global COVID-19 vaccines against SARS-CoV-2 Variants: A systematic review and meta-analysis. Front. Med. 2022;9:820544. doi: 10.3389/fmed.2022.820544.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.820544</ArticleId><ArticleId IdType="pmc">PMC9160927</ArticleId><ArticleId IdType="pubmed">35665358</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes L.D., Ingram J., Sculthorpe N.F. More Than 100 Persistent Symptoms of SARS-CoV-2 (Long COVID): A scoping review. Front. Med. 2021;8:750378. doi: 10.3389/fmed.2021.750378.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.750378</ArticleId><ArticleId IdType="pmc">PMC8591053</ArticleId><ArticleId IdType="pubmed">34790680</ArticleId></ArticleIdList></Reference><Reference><Citation>Amdal C.D., Pe M., Falk R.S., Piccinin C., Bottomley A., Arraras J.I., Darlington A.S., Hofs&#xf8; K., Holzner B., J&#xf8;rgensen N.M.H., et al. Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review. Qual. Life Res. 2021;30:3367&#x2013;3381. doi: 10.1007/s11136-021-02908-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-021-02908-z</ArticleId><ArticleId IdType="pmc">PMC8214069</ArticleId><ArticleId IdType="pubmed">34146226</ArticleId></ArticleIdList></Reference><Reference><Citation>Tene L., Bergroth T., Eisenberg A., Ben David S.S., Chodick G. Risk factors, health outcomes, healthcare services utilization, and direct medical costs of long COVID patient. Int. J. Infect. Dis. 2023;128:3&#x2013;10. doi: 10.1016/j.ijid.2022.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.12.002</ArticleId><ArticleId IdType="pubmed">36529373</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens M., Duarte R.V., De Smedt A., Putman K., Callens J., Billot M., Roulaud M., Rigoard P., Goudman L. Health-related quality of life in persons post-COVID-19 infection in comparison to normative controls and chronic pain patients. Front. Public Health. 2022;10:991572. doi: 10.3389/fpubh.2022.991572.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.991572</ArticleId><ArticleId IdType="pmc">PMC9632164</ArticleId><ArticleId IdType="pubmed">36339175</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2019;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Florencio L.L., Cuadrado M.L., Plaza-Manzano G., Navarro-Santana M. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Intern. Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post COVID-19 condition or long COVID: A meta-analysis and systematic review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi M.S., Omrani O.A., Fawzy N.A., Shaar B.A., Almamlouk R., Riaz M., Obeidat M., Obeidat Y., Gerberi D., Taha R.M., et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: A systematic review and meta-analysis. Clin. Microbiol. Infect. 2022;28:657&#x2013;666. doi: 10.1016/j.cmi.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens. 2022;11:269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P., Gorelik Y., Gausi B., Bernstine T., Edelstein M. Characterization of post-COVID syndromes by symptom cluster and time period up to 12 months post-infection: A systematic review and meta-analysis. Int. J. Infect. Dis. 2023;134:1&#x2013;7. doi: 10.1016/j.ijid.2023.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.05.003</ArticleId><ArticleId IdType="pubmed">37150350</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators. Hanson S.W., Abbafati C., Aerts J.G., Al-Aly Z., Ashbaugh C., Ballouz T., Blyuss O., Bobkova P., Bonsel G., et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604&#x2013;1615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M., Udeh R., Yon D.K., Lee S.W., Dolja-Gore X., McEVoy M., Kenna T., Jacob L., L&#xf3;pez S&#xe1;nchez G.F., Koyanagi A., et al. A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences. J. Med. Virol. 2023;95:e28852. doi: 10.1002/jmv.28852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28852</ArticleId><ArticleId IdType="pubmed">37288652</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji G., Chen C., Zhou M., Wen W., Wang C., Tang J., Cheng Y., Wu Q., Zhang X., Wang M., et al. Post-COVID-19 fatigue among COVID-19 in patients discharged from hospital: A meta-analysis. J. Infect. 2022;84:722&#x2013;746. doi: 10.1016/j.jinf.2022.01.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.01.030</ArticleId><ArticleId IdType="pmc">PMC8801976</ArticleId><ArticleId IdType="pubmed">35101536</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Navarro-Santana M., Plaza-Manzano G., Palacios-Ce&#xf1;a Arendt-Nielsen L. Time course prevalence of Post-COVID pain symptoms of musculoskeletal origin in patients who had survived to SARS-CoV-2 infection: A systematic review and meta-analysis. Pain. 2022;163:1220&#x2013;1231. doi: 10.1097/j.pain.0000000000002496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002496</ArticleId><ArticleId IdType="pubmed">34561390</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjenberg Z., Leng S., Tascini C., Garg M., Misso K., El Guerche Seblain C., Shaikh N. Risk of long COVID main symptoms after SARS-CoV-2 infection: A systematic review and meta-analysis. Sci. Rep. 2023;13:15332. doi: 10.1038/s41598-023-42321-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-42321-9</ArticleId><ArticleId IdType="pmc">PMC10504382</ArticleId><ArticleId IdType="pubmed">37714919</ArticleId></ArticleIdList></Reference><Reference><Citation>Perumal R., Shunmugam L., Naidoo K., Abdool Karim S.S., Wilkins D., Garzino-Demo A., Brechot C., Parthasarathy S., Vahlne A., Nikolich J.&#x17d;. Long COVID: A review and proposed visualization of the complexity of long COVID. Front. Immunol. 2023;14:1117464. doi: 10.3389/fimmu.2023.1117464.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1117464</ArticleId><ArticleId IdType="pmc">PMC10157068</ArticleId><ArticleId IdType="pubmed">37153597</ArticleId></ArticleIdList></Reference><Reference><Citation>Boaventura P., Macedo S., Ribeiro F., Jaconiano S., Soares P. Post-COVID-19 condition: Where are we now? Life. 2022;12:517. doi: 10.3390/life12040517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12040517</ArticleId><ArticleId IdType="pmc">PMC9029703</ArticleId><ArticleId IdType="pubmed">35455008</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumoli N., Conte G., Evangelista I., Cei M., Mazzone A., Colombo A. Post-COVID or long-COVID: Two different conditions or the same? J. Infect. Public Health. 2021;14:1349&#x2013;1350. doi: 10.1016/j.jiph.2021.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2021.08.019</ArticleId><ArticleId IdType="pmc">PMC8372476</ArticleId><ArticleId IdType="pubmed">34426096</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarialiabad H., Taghrir M.H., Abdollahi A., Ghahramani N., Kumar M., Paydar S., Razani B., Mwangi J., Asadi-Pooya A.A., Malekmakan L., et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49:1163&#x2013;1186. doi: 10.1007/s15010-021-01666-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Cegolon L., Mauro M., Sansone D., Tassinari A., Gobba F.M., Modenese A., Casolari L., Liviero F., Pavanello S., Scapellato M.L., et al. A Multi-center study investigating long COVID-19 in healthcare workers from North-Eastern Italy: Prevalence, risk factors and the impact of pre-existing humoral immunity-ORCHESTRA Project. Vaccines. 2023;11:1769. doi: 10.3390/vaccines11121769.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11121769</ArticleId><ArticleId IdType="pubmed">38140174</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng B., Daines L., Han Q., Hurst J.R., Pfeffer P., Shankar-Hari M., Elneima O., Walker S., Brown J.S., Siddiqui S., et al. Prevalence, risk factors and treatments for post-COVID-19 breathlessness: A systematic review and meta-analysis. Eur. Respir. Rev. 2022;31:220071. doi: 10.1183/16000617.0071-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0071-2022</ArticleId><ArticleId IdType="pmc">PMC9724798</ArticleId><ArticleId IdType="pubmed">36323418</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Florencio L.L., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Palacios-Ce&#xf1;a D., Raveendran A.V. Proposed integrative model for post-COVID symptoms. Diabetes Metab. Syndr. 2021;15:102159. doi: 10.1016/j.dsx.2021.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.05.032</ArticleId><ArticleId IdType="pmc">PMC8168334</ArticleId><ArticleId IdType="pubmed">34186367</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Are patients exhibiting post-Coronavirus Disease (COVID) symptoms at 12 months the same at 5 or 9 months? The fluctuating nature of Post-COVID. Clin. Infect. Dis. 2022;75:e1208. doi: 10.1093/cid/ciac007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac007</ArticleId><ArticleId IdType="pmc">PMC9383161</ArticleId><ArticleId IdType="pubmed">34989807</ArticleId></ArticleIdList></Reference><Reference><Citation>Korompoki E., Gavriatopoulou M., Hicklen R.S., Ntanasis-Stathopoulos I., Kastritis E., Fotiou D., Stamatelopoulos K., Terpos E., Kotanidou A., Hagberg C.A., et al. Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review. J. Infect. 2021;83:1&#x2013;16. doi: 10.1016/j.jinf.2021.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8118709</ArticleId><ArticleId IdType="pubmed">33992686</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE); Royal College of General Practitioners; Healthcare Improvement Scotland SIGN. COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. London: National Institute for Health and Care Excellence. 2020.  [(accessed on 1 October 2023)].  Available online:  https://www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Baig A.M. Chronic COVID Syndrome: Need for an appropriate medical terminology for Long-COVID and COVID Long-Haulers. J. Med. Virol. 2021;93:2555&#x2013;2556. doi: 10.1002/jmv.26624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S., O&#x2019;Connor R., Sivan M. Long COVID and chronic COVID syndromes. J. Med. Virol. 2021;93:1242&#x2013;1243. doi: 10.1002/jmv.26587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26587</ArticleId><ArticleId IdType="pmc">PMC7675759</ArticleId><ArticleId IdType="pubmed">33034893</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. The lasting misery of coronavirus long-haulers. Nature. 2020;585:339&#x2013;341. doi: 10.1038/d41586-020-02598-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02598-6</ArticleId><ArticleId IdType="pubmed">32929257</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Long COVID: Current definition. Infection. 2022;50:285&#x2013;286. doi: 10.1007/s15010-021-01696-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01696-5</ArticleId><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter R.S., Nieters A., Kr&#xe4;usslich H.G., Brockmann S.O., G&#xf6;pel S., Kindle G., Merle U., Steinacker J.M., Rothenbacher D., Kern W.V., et al. Post-acute sequelae of COVID-19 six to 12 months after infection: Population-based study. BMJ. 2022;379:e071050. doi: 10.1136/bmj-2022-071050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071050</ArticleId><ArticleId IdType="pmc">PMC9557001</ArticleId><ArticleId IdType="pubmed">36229057</ArticleId></ArticleIdList></Reference><Reference><Citation>Diem L., Schwarzwald A., Friedli C., Hammer H., Gomes-Fregolente L., Warncke J., Weber L., Kamber N., Chan A., Bassetti C., et al. Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey study. CNS Neurosci. Ther. 2022;28:1953&#x2013;1963. doi: 10.1111/cns.13938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13938</ArticleId><ArticleId IdType="pmc">PMC9538958</ArticleId><ArticleId IdType="pubmed">35975339</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long COVID-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal F.M., Lam K., Sounderajah V., Clarke J.M., Ashrafian H., Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899. doi: 10.1016/j.eclinm.2021.100899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglietta G., Diodati F., Puntoni M., Lazzarelli S., Marcomini B., Patrizi L., Caminiti C. Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022;11:1541. doi: 10.3390/jcm11061541.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11061541</ArticleId><ArticleId IdType="pmc">PMC8948827</ArticleId><ArticleId IdType="pubmed">35329867</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C., Huggins C.F., Kwong A.S.F., Silverwood R.J., Di Gessa G., et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat. Commun. 2022;13:3528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., de Oliveira M.H.S., Peligro P.J., Velasco J.V., Macaranas I., Ver A.T., Pangilinan F.C., Pastrana A., Goldrich N., Kavteladze D., et al. Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: A systematic review and meta-analysis. J. Clin. Med. 2022;11:7314. doi: 10.3390/jcm11247314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk factors associated with post-COVID-19 condition: A systematic review and meta-analysis. JAMA Intern. Med. 2023;183:566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Bwire G.M. Coronavirus: Why men are more vulnerable to covid-19 than women? SN Compr. Clin. Med. 2020;2:874&#x2013;876. doi: 10.1007/s42399-020-00341-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00341-w</ArticleId><ArticleId IdType="pmc">PMC7271824</ArticleId><ArticleId IdType="pubmed">32838138</ArticleId></ArticleIdList></Reference><Reference><Citation>Spicuzza L., Campisi R., Alia S., Prestifilippo S., Giuffrida M.L., Angileri L., Ciancio N., Vancheri C. Female sex affects respiratory function and exercise ability in patients recovered from COVID-19 pneumonia. J. Womens Health. 2023;32:18&#x2013;23. doi: 10.1089/jwh.2022.0104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2022.0104</ArticleId><ArticleId IdType="pubmed">36450116</ArticleId></ArticleIdList></Reference><Reference><Citation>Sha J., Qie G., Yao Q., Sun W., Wang C., Zhang Z., Wang X., Wang P., Jiang J., Bai X., et al. Sex differences on clinical characteristics, severity, and mortality in adult patients with COVID-19: A multicentre retrospective study. Front. Med. 2021;8:607059. doi: 10.3389/fmed.2021.607059.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.607059</ArticleId><ArticleId IdType="pmc">PMC7906985</ArticleId><ArticleId IdType="pubmed">33644092</ArticleId></ArticleIdList></Reference><Reference><Citation>Barek M.A., Aziz M.A., Islam M.S. Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 cases. Heliyon. 2020;6:e05684. doi: 10.1016/j.heliyon.2020.e05684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2020.e05684</ArticleId><ArticleId IdType="pmc">PMC7737518</ArticleId><ArticleId IdType="pubmed">33344791</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z., Peng F., Xu B., Zhao J., Liu H., Peng J., Li Q., Jiang C., Zhou Y., Liu S., et al. Risk factors of critical and mortal COVID-19 cases: A systematic literature review and meta-analysis. J. Infect. 2020;81:e16&#x2013;e25. doi: 10.1016/j.jinf.2020.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC7177098</ArticleId><ArticleId IdType="pubmed">32335169</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahu A.K., Mathew R., Aggarwal P., Nayer J., Bhoi S., Satapathy S., Ekka M. Clinical determinants of severe COVID-19 Disease: A systematic review and meta-analysis. J. Glob. Infect. Dis. 2021;13:13&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8054797</ArticleId><ArticleId IdType="pubmed">33911447</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone D., Tassinari A., Valentinotti R., Kontogiannis D., Ronchese F., Centonze S., Maggiore A., Cegolon L., Filon F.L. Persistence of symptoms 15 months since COVID-19 diagnosis: Prevalence, risk factors and residual work ability. Life. 2022;13:97. doi: 10.3390/life13010097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13010097</ArticleId><ArticleId IdType="pmc">PMC9862952</ArticleId><ArticleId IdType="pubmed">36676046</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V. Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab. Syndr. 2021;15:145&#x2013;146. doi: 10.1016/j.dsx.2020.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.12.025</ArticleId><ArticleId IdType="pmc">PMC7737559</ArticleId><ArticleId IdType="pubmed">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., Van den Heede K. Pathophysiology and mechanism of long COVID: A comprehensive review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif Z.A., Gomez C.R., Connors T.J., Henrich T.J., Reeves W.B., RECOVER Mechanistic Pathway Task Force Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC) Elife. 2023;12:e86002. doi: 10.7554/eLife.86002.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86002</ArticleId><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell J.S., Chappell K.J. Chronic SARS-CoV-2, a Cause of Post-acute COVID-19 Sequelae (Long-COVID)? Front. Microbiol. 2021;12:724654. doi: 10.3389/fmicb.2021.724654.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.724654</ArticleId><ArticleId IdType="pmc">PMC8365243</ArticleId><ArticleId IdType="pubmed">34408742</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B., Julg B., Mohandas S., Bradfute S.B., RECOVER Mechanistic Pathways Task Force Viral persistence, reactivation, and mechanisms of long COVID. Elife. 2023;12:e86015. doi: 10.7554/eLife.86015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B., Aleman S., Bach K., Boribong B.P., Buggert M., Cherry S., Chertow D.S., Davies H.E., Dupont C.L., et al. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) Nat. Immunol. 2023;24:1616&#x2013;1627. doi: 10.1038/s41590-023-01601-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01601-2</ArticleId><ArticleId IdType="pubmed">37667052</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussani R., Zentilin L., Correa R., Colliva A., Silvestri F., Zacchigna S., Collesi C., Giacca M. Persistent SARS-CoV-2 infection in patients seemingly recovered from COVID-19. J. Pathol. 2023;259:254&#x2013;263. doi: 10.1002/path.6035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.6035</ArticleId><ArticleId IdType="pmc">PMC10107739</ArticleId><ArticleId IdType="pubmed">36651103</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S.R., Ramelli S.C., Grazioli A., Chung J.Y., Singh M., Yinda C.K., Winkler C.W., Sun J., Dickey J.M., Ylaya K., et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A., Koch R., Jukic A., Pfister A., Meyer M., R&#xf6;ssler A., Kimpel J., Adolph T.E., Tilg H. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163:495&#x2013;506. doi: 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X.G., Li J.Z., Alter G., Walt D.R. Persistent circulating Severe Acute Respiratory Syndrome Coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin. Infect. Dis. 2023;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian F., Chen Z., Feng Q. Nirmatrelvir-ritonavir compared with other antiviral drugs for the treatment of COVID-19 patients: A systematic review and meta-analysis. J. Med. Virol. 2023;95:e28732. doi: 10.1002/jmv.28732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28732</ArticleId><ArticleId IdType="pubmed">37183808</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall G.D., Jr. The pathophysiology of post-acute sequelae of COVID-19 (PASC): Possible role for persistent inflammation. Asia Pac. Allergy. 2023;13:77&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10287107</ArticleId><ArticleId IdType="pubmed">37388814</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group Clinical characteristics with inflammation profiling of Long-COVID and association with one-year recovery following hospitalisation in the UK: A prospective observational study. Lancet Respir. Med. 2022;10:761&#x2013;775. doi: 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin J.X., Agbana Y.L., Sun Z.S., Fei S.W., Zhao H.Q., Zhou X.N., Chen J.H., Kassegne K. Increased interleukin-6 is associated with long COVID-19: A systematic review and meta-analysis. Infect. Dis. Poverty. 2023;12:43. doi: 10.1186/s40249-023-01086-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-023-01086-z</ArticleId><ArticleId IdType="pmc">PMC10123579</ArticleId><ArticleId IdType="pubmed">37095536</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y.J., Liu S.H., Manachevakul S., Lee T.A., Kuo C.T., Bello D. Biomarkers in long COVID-19: A systematic review. Front. Med. 2023;10:1085988. doi: 10.3389/fmed.2023.1085988.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1085988</ArticleId><ArticleId IdType="pmc">PMC9895110</ArticleId><ArticleId IdType="pubmed">36744129</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams E.S., Martins T.B., Shah K.S., Hill H.R., Coiras M., Spivak A.M., Planelles V. Cytokine deficiencies in patients with long-COVID. J. Clin. Cell. Immunol. 2022;13:672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894377</ArticleId><ArticleId IdType="pubmed">36742994</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavakolpour S., Rakhshandehroo T., Wei E.X., Rashidian M. Lymphopenia during the COVID-19 infection: What it shows and what can be learned. Immunol. Lett. 2020;225:31&#x2013;32. doi: 10.1016/j.imlet.2020.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2020.06.013</ArticleId><ArticleId IdType="pmc">PMC7305732</ArticleId><ArticleId IdType="pubmed">32569607</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawley H.B. Long COVID: Clinical findings, pathology, and endothelial molecular mechanisms. Am. J. Med. 2023 doi: 10.1016/j.amjmed.2023.08.008. in press .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.08.008</ArticleId><ArticleId IdType="pubmed">37704072</ArticleId></ArticleIdList></Reference><Reference><Citation>Griesel M., Wagner C., Mikolajewska A., Stegemann M., Fichtner F., Metzendorf M.I., Nair A.A., Daniel J., Fischer A.L., Skoetz N. Inhaled corticosteroids for the treatment of COVID-19. Cochrane Database Syst. Rev. 2022;3:CD015125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905579</ArticleId><ArticleId IdType="pubmed">35262185</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner C., Griesel M., Mikolajewska A., Metzendorf M.I., Fischer A.L., Stegemann M., Spagl M., Nair A.A., Daniel J., Fichtner F., et al. Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence. Cochrane Database Syst. Rev. 2022;11:CD014963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9670242</ArticleId><ArticleId IdType="pubmed">36385229</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenes Bonet D., Caguana V&#xe9;lez O.A., Duran Jord&#xe0; X., Comas Serrano M., Posso Rivera M., Admetll&#xf3; M., Herranz Blasco A., Cuadrado Godia E., Marco Navarro E., Martin Ezquerra G., et al. Treatment of COVID-19 during the acute phase in hospitalized patients decreases post-acute sequelae of COVID-19. J. Clin. Med. 2023;12:4158. doi: 10.3390/jcm12124158.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12124158</ArticleId><ArticleId IdType="pmc">PMC10299438</ArticleId><ArticleId IdType="pubmed">37373850</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z.-W., Zhang H.-Z., Liu C., Dong K. Autoantibodies in COVID-19: Frequency and function. Autoimmun. Rev. 2021;20:102754. doi: 10.1016/j.autrev.2021.102754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102754</ArticleId><ArticleId IdType="pmc">PMC7813482</ArticleId><ArticleId IdType="pubmed">33476817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld M., Tincani A., Andreoli L., Cattalini M., Greenbaum A., Kanduc D., Alijotas-Reig J., Zinserling V., Semenova N., Amital H., et al. COVID-19 and autoimmunity. Autoimmun. Rev. 2020;19:102597. doi: 10.1016/j.autrev.2020.102597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102597</ArticleId><ArticleId IdType="pmc">PMC7289100</ArticleId><ArticleId IdType="pubmed">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Blagova O., Varionchik N., Zaidenov V., Savina P., Sarkisova N. Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID-19. Eur. J. Immunol. 2021;51:893&#x2013;902. doi: 10.1002/eji.202048930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202048930</ArticleId><ArticleId IdType="pubmed">33368288</ArticleId></ArticleIdList></Reference><Reference><Citation>Harne R., Williams B., Abdelal H.F.M., Baldwin S.L., Coler R.N. SARS-CoV-2 infection and immune responses. AIMS Microbiol. 2023;9:245&#x2013;276. doi: 10.3934/microbiol.2023015.</Citation><ArticleIdList><ArticleId IdType="doi">10.3934/microbiol.2023015</ArticleId><ArticleId IdType="pmc">PMC10113164</ArticleId><ArticleId IdType="pubmed">37091818</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K., Peluso M.J., Luo X., Thomas R., Shin M.-G., Neidleman J., Andrew A., Young K., Ma T., Hoh R., et al. Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2. bioRxiv. 2023 doi: 10.1101/2023.02.09.527892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.02.09.527892</ArticleId><ArticleId IdType="pmc">PMC10834368</ArticleId><ArticleId IdType="pubmed">38212464</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deveau T.M., Munter S.E., Peluso M.J., Deveau T.-M., Munter S.E., Ryder D., Buck A., Lu S., Goldberg S.A., et al. Evidence of recent Epstein-Barr virus reactivation in individuals experiencing long COVID. medRxiv. 2022 doi: 10.1101/2022.06.21.22276660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.21.22276660</ArticleId></ArticleIdList></Reference><Reference><Citation>Banko A., Miljanovic D., Cirkovic A. Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field. Int. J. Infect. Dis. 2023;130:108&#x2013;125. doi: 10.1016/j.ijid.2023.01.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.01.036</ArticleId><ArticleId IdType="pmc">PMC9889115</ArticleId><ArticleId IdType="pubmed">36736577</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo J., Spittle D.A., Newnham M. COVID-19, immunothrombosis and venous thromboembolism: Biological mechanisms. Thorax. 2021;76:412&#x2013;420. doi: 10.1136/thoraxjnl-2020-216243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216243</ArticleId><ArticleId IdType="pubmed">33408195</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro L., Zaccone V., Falsetti L., Ruggieri V., Danese M., Miro C., Di Giorgio A., Nesci A., D&#x2019;Alessandro A., Moroncini G., et al. Role of endothelium in cardiovascular sequelae of long COVID. Biomedicines. 2023;11:2239. doi: 10.3390/biomedicines11082239.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11082239</ArticleId><ArticleId IdType="pmc">PMC10452509</ArticleId><ArticleId IdType="pubmed">37626735</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgieva E., Ananiev J., Yovchev Y., Arabadzhiev G., Abrashev H., Abrasheva D., Atanasov V., Kostandieva R., Mitev M., Petkova-Parlapanska K., et al. COVID-19 complications: Oxidative stress, inflammation, and mitochondrial and endothelial dysfunction. Int. J. Mol. Sci. 2023;24:14876. doi: 10.3390/ijms241914876.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241914876</ArticleId><ArticleId IdType="pmc">PMC10573237</ArticleId><ArticleId IdType="pubmed">37834324</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabani Z., Liu J., Su H. Vascular dysfunctions contribute to the long-term cognitive deficits following COVID-19. Biology. 2023;12:1106. doi: 10.3390/biology12081106.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology12081106</ArticleId><ArticleId IdType="pmc">PMC10451811</ArticleId><ArticleId IdType="pubmed">37626992</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanini G., Selleri V., Roncati L., Coppi F., Nasi M., Farinetti A., Manenti A., Pinti M., Mattioli A.V. Vascular &#x201c;Long COVID&#x201d;: A new vessel disease? Angiology. 2023;75 doi: 10.1177/00033197231153204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00033197231153204</ArticleId><ArticleId IdType="pmc">PMC9895315</ArticleId><ArticleId IdType="pubmed">36652923</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Corona N.C., L&#xf3;pez-Ortega O., P&#xe9;rez-Mart&#xed;nez C.A., Mart&#xed;nez-Castillo M., De Jes&#xfa;s-Gonz&#xe1;lez L.A., Le&#xf3;n-Reyes G., Le&#xf3;n-Ju&#xe1;rez M. Dynamics of the microbiota and its relationship with post-COVID-19 syndrome. Int. J. Mol. Sci. 2023;24:14822. doi: 10.3390/ijms241914822.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241914822</ArticleId><ArticleId IdType="pmc">PMC10573029</ArticleId><ArticleId IdType="pubmed">37834270</ArticleId></ArticleIdList></Reference><Reference><Citation>Plummer A.M., Matos Y.L., Lin H.C., Ryman S.G., Birg A., Quinn D.K., Parada A.N., Vakhtin A.A. Gut-brain pathogenesis of post-acute COVID-19 neurocognitive symptoms. Front. Neurosci. 2023;17:1232480. doi: 10.3389/fnins.2023.1232480.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2023.1232480</ArticleId><ArticleId IdType="pmc">PMC10568482</ArticleId><ArticleId IdType="pubmed">37841680</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., Yeoh Y.K., Lui G.C., Ng S.S.S., Zhang F., Li A.Y.L., Lu W., Hui D.S., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Settanni C.R., Ianiro G., Ponziani F.R., Bibb&#xf2; S., Segal J.P., Cammarota G., Gasbarrini A. COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms. World J. Gastroenterol. 2021;27:7433&#x2013;7445. doi: 10.3748/wjg.v27.i43.7433.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v27.i43.7433</ArticleId><ArticleId IdType="pmc">PMC8613742</ArticleId><ArticleId IdType="pubmed">34887641</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall P.A., Sheeran P., Fong G.T., Cheah C.S.L., Oremus M., Liu-Ambrose T., Sakib M.N., Butt Z.A., Ayaz H., Jandu N., et al. Biobehavioral Aspects of the COVID-19 Pandemic: A Review. Psychosom. Med. 2021;83:309&#x2013;321. doi: 10.1097/PSY.0000000000000932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000000932</ArticleId><ArticleId IdType="pmc">PMC8115744</ArticleId><ArticleId IdType="pubmed">33790201</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., Palladini M., Poletti S., Benedetti F. Post-COVID-19 depressive symptoms: Epidemiology, Pathophysiology, and pharmacological treatment. CNS Drugs. 2022;36:681&#x2013;702. doi: 10.1007/s40263-022-00931-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-022-00931-3</ArticleId><ArticleId IdType="pmc">PMC9210800</ArticleId><ArticleId IdType="pubmed">35727534</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Jassas H.K., Al-Hakeim H.K., Maes M. Intersections between pneumonia, lowered oxygen saturation percentage and immune activation mediate depression, anxiety, and chronic fatigue syndrome-like symptoms due to COVID-19: A nomothetic network approach. J. Affect. Disord. 2022;15:233&#x2013;245. doi: 10.1016/j.jad.2021.10.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.10.039</ArticleId><ArticleId IdType="pmc">PMC8541833</ArticleId><ArticleId IdType="pubmed">34699853</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottemanne H., Gouraud C., Hulot J.S., Blanchard A., Ranque B., Lahlou-Lafor&#xea;t K., Limosin F., G&#xfc;nther S., Lebeaux D., Lemogne C. Do anxiety and depression predict persistent physical symptoms after a severe COVID-19 episode? A prospective study. Front. Psychiatry. 2021;12:757685. doi: 10.3389/fpsyt.2021.757685.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.757685</ArticleId><ArticleId IdType="pmc">PMC8631493</ArticleId><ArticleId IdType="pubmed">34858230</ArticleId></ArticleIdList></Reference><Reference><Citation>Merikanto I., Dauvilliers Y., Chung F., Wing Y.K., De Gennaro L., Holzinger B., Bjorvatn B., Morin C.M., Penzel T., Benedict C., et al. Sleep symptoms are essential features of long-COVID&#x2014;Comparing healthy controls with COVID-19 cases of different severity in the international COVID sleep study (ICOSS-II) J. Sleep Res. 2022;32:e13754. doi: 10.1111/jsr.13754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jsr.13754</ArticleId><ArticleId IdType="pmc">PMC9874584</ArticleId><ArticleId IdType="pubmed">36208038</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacho-Hern&#xe1;ndez J.C., Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Fuensalida-Novo S., Jim&#xe9;nez-Antona C., Ortega-Santiago R., Cigar&#xe1;n-Mendez M. Sleep quality mediates the effect of sensitization-associated symptoms, anxiety, and depression on quality of life in individuals with post-COVID-19 pain. Brain Sci. 2022;12:1363. doi: 10.3390/brainsci12101363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12101363</ArticleId><ArticleId IdType="pmc">PMC9599807</ArticleId><ArticleId IdType="pubmed">36291297</ArticleId></ArticleIdList></Reference><Reference><Citation>Aletaha D. Precision medicine and management of rheumatoid arthritis. J. Autoimmun. 2020;110:102405. doi: 10.1016/j.jaut.2020.102405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102405</ArticleId><ArticleId IdType="pubmed">32276742</ArticleId></ArticleIdList></Reference><Reference><Citation>National Research Council Committee on AFfDaNToD . The National Academies Collection: Reports funded by National Institutes of Health. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. National Academies Press; Washington, DC, USA: 2011.</Citation><ArticleIdList><ArticleId IdType="pubmed">22536618</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetta H.F., Muhammad K., Algammal A.M., Ramadan H., Abdel-Rahman M.S., Mabrok M., Koneru G., Elkady A.A., El-Saber Batiha G., Waheed Y., et al. Mapping the effect of drugs on ACE2 as a novel target site for COVID-19 therapy. Eur. Rev. Med. Pharmacol. Sci. 2021;25:3923&#x2013;3932.</Citation><ArticleIdList><ArticleId IdType="pubmed">34109607</ArticleId></ArticleIdList></Reference><Reference><Citation>de Bruin N., Schneider A.K., Reus P., Talmon S., Ciesek S., Bojkova D., Cinatl J., Lodhi I., Charlesworth B., Sinclair S., et al. Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol do not influence ACE2 expression and activity in vitro or in mice and do not exacerbate in-vitro SARS-CoV-2 infection. Int. J. Mol. Sci. 2022;23:1049. doi: 10.3390/ijms23031049.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031049</ArticleId><ArticleId IdType="pmc">PMC8835123</ArticleId><ArticleId IdType="pubmed">35162972</ArticleId></ArticleIdList></Reference><Reference><Citation>Darbeheshti F., Abolhassani H., Bashashati M., Ghavami S., Shahkarami S., Zoghi S., Gupta S., Orange J.S., Ochs H.D., Rezaei N. Coronavirus: Pure infectious disease or genetic predisposition. Adv. Exp. Med. Biol. 2021;1318:91&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">33973174</ArticleId></ArticleIdList></Reference><Reference><Citation>Darbeheshti F., Rezaei N. Genetic Predisposition Models to COVID-19 Infection. Med. Hypotheses. 2020;142:109818. doi: 10.1016/j.mehy.2020.109818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109818</ArticleId><ArticleId IdType="pmc">PMC7202332</ArticleId><ArticleId IdType="pubmed">32416414</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y., Zhao J., Martin W., Kallianpur A., Chung M.K., Jehi L., Sharifi N., Erzurum S., Eng C., Cheng F. New insights into genetic susceptibility of COVID-19: An ACE2 and TMPRSS2 polymorphism analysis. BMC Med. 2020;18:216. doi: 10.1186/s12916-020-01673-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01673-z</ArticleId><ArticleId IdType="pmc">PMC7360473</ArticleId><ArticleId IdType="pubmed">32664879</ArticleId></ArticleIdList></Reference><Reference><Citation>Saengsiwaritt W., Jittikoon J., Chaikledkaew U., Udomsinprasert W. Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis. Rev. Med. Virol. 2022;8:e2323. doi: 10.1002/rmv.2323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2323</ArticleId><ArticleId IdType="pubmed">34997794</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta K., Kaur G., Pathak T., Banerjee I. Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity. Gene. 2022;844:146790. doi: 10.1016/j.gene.2022.146790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2022.146790</ArticleId><ArticleId IdType="pmc">PMC9384365</ArticleId><ArticleId IdType="pubmed">35987511</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta P.L., Byrne A.B., Hijano D.R., Talarico L.B. Human type I interferon antiviral effects in respiratory and reemerging viral infections. J. Immunol. Res. 2020;2020:1372494. doi: 10.1155/2020/1372494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/1372494</ArticleId><ArticleId IdType="pmc">PMC7231083</ArticleId><ArticleId IdType="pubmed">32455136</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Qin L., Zhao Y., Zhang P., Xu B., Li K., Liang L., Zhang C., Dai Y., Feng Y., et al. Interferon-induced transmembrane protein 3 genetic variant Rs12252-C associated with disease severity in Coronavirus Disease 2019. J. Infect. Dis. 2020;222:34&#x2013;37. doi: 10.1093/infdis/jiaa224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa224</ArticleId><ArticleId IdType="pmc">PMC7197559</ArticleId><ArticleId IdType="pubmed">32348495</ArticleId></ArticleIdList></Reference><Reference><Citation>Karcioglu Batur L., Hekim N. Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID-2019) in 23 countries. J. Med. Virol. 2021;93:5853&#x2013;5863. doi: 10.1002/jmv.27127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27127</ArticleId><ArticleId IdType="pmc">PMC8242628</ArticleId><ArticleId IdType="pubmed">34081354</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Arendt-Nielsen L., D&#xed;az-Gil G., G&#xf3;mez-Esquer F., Gil-Crujera A., G&#xf3;mez-S&#xe1;nchez S.M., Ambite-Quesada S., Palomar-Gallego M.A., Pellicer-Valero O.J., Giordano R. Genetic association between ACE2 (rs2285666 and rs2074192) and TMPRSS2 (rs12329760 and rs2070788) polymorphisms with post-COVID symptoms in previously hospitalized COVID-19 survivors. Genes. 2022;13:1935. doi: 10.3390/genes13111935.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes13111935</ArticleId><ArticleId IdType="pmc">PMC9690177</ArticleId><ArticleId IdType="pubmed">36360172</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Giordano R., D&#xed;az-Gil G., G&#xf3;mez-Esquer F., Ambite-Quesada S., Palomar-Gallego M.A., Arendt-Nielsen L. Post-COVID pain is not associated with inflammatory polymorphisms in people who had been hospitalized by COVID-19. J. Clin. Med. 2022;11:5645. doi: 10.3390/jcm11195645.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11195645</ArticleId><ArticleId IdType="pmc">PMC9570972</ArticleId><ArticleId IdType="pubmed">36233516</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Giordano R., D&#xed;az-Gil G., Gil-Crujera A., G&#xf3;mez-S&#xe1;nchez S.M., Ambite-Quesada S., Arendt-Nielsen L. Are pain polymorphisms associated with the risk and phenotype of post-COVID pain in previously hospitalized COVID-19 survivors? Genes. 2022;13:1336. doi: 10.3390/genes13081336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes13081336</ArticleId><ArticleId IdType="pmc">PMC9394327</ArticleId><ArticleId IdType="pubmed">35893072</ArticleId></ArticleIdList></Reference><Reference><Citation>Atlante S., Mongelli A., Barbi V., Martelli F., Farsetti A., Gaetano C. The epigenetic implication in coronavirus infection and therapy. Clin. Epigenet. 2020;12:156. doi: 10.1186/s13148-020-00946-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-020-00946-x</ArticleId><ArticleId IdType="pmc">PMC7576975</ArticleId><ArticleId IdType="pubmed">33087172</ArticleId></ArticleIdList></Reference><Reference><Citation>Capp J.P. Interplay between genetic, epigenetic, and gene expression variability: Considering complexity in evolvability. Evol. Appl. 2021;14:893&#x2013;901. doi: 10.1111/eva.13204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eva.13204</ArticleId><ArticleId IdType="pmc">PMC8061278</ArticleId><ArticleId IdType="pubmed">33897810</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A., Netea M.G. Trained innate immunity, epigenetics, and COVID-19. N. Engl. J. Med. 2020;383:1078&#x2013;1080. doi: 10.1056/NEJMcibr2011679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2011679</ArticleId><ArticleId IdType="pubmed">32905684</ArticleId></ArticleIdList></Reference><Reference><Citation>Corley M.J., Pang A.P.S., Dody K., Mudd P.A., Patterson B.K., Seethamraju H., Bram Y., Peluso M.J., Torres L., Iyer N.S., et al. Genome-Wide DNA Methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19. J. Leukoc. Biol. 2021;110:21&#x2013;26. doi: 10.1002/JLB.5HI0720-466R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.5HI0720-466R</ArticleId><ArticleId IdType="pmc">PMC8013321</ArticleId><ArticleId IdType="pubmed">33464637</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey A., Vaishak K., Deka D., Radhakrishnan A.K., Paul S., Shanmugam P., Daniel A.P., Pathak S., Duttaroy A.K., Banerjee A. Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: An updated review. Infection. 2023;51:1603&#x2013;1618. doi: 10.1007/s15010-023-02017-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-023-02017-8</ArticleId><ArticleId IdType="pmc">PMC10008189</ArticleId><ArticleId IdType="pubmed">36906872</ArticleId></ArticleIdList></Reference><Reference><Citation>Balnis J., Madrid A., Hogan K.J., Drake L.A., Chieng H.C., Tiwari A., Vincent C.E., Chopra A., Vincent P.A., Robek M.D., et al. Blood DNA Methylation and COVID-19 outcomes. Clin. Epigenet. 2021;13:118. doi: 10.1186/s13148-021-01102-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-021-01102-9</ArticleId><ArticleId IdType="pmc">PMC8148415</ArticleId><ArticleId IdType="pubmed">34034806</ArticleId></ArticleIdList></Reference><Reference><Citation>Balnis J., Madrid A., Hogan K.J., Drake L.A., Adhikari A., Vancavage R., Singer H.A., Alisch R.S., Jaitovich A. Whole-Genome methylation sequencing reveals that COVID-19-induced epigenetic dysregulation remains 1 year after hospital discharge. Am. J. Respir. Cell Mol. Biol. 2023;68:594&#x2013;597. doi: 10.1165/rcmb.2022-0433LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2022-0433LE</ArticleId><ArticleId IdType="pmc">PMC10174161</ArticleId><ArticleId IdType="pubmed">37125894</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Riskedal E., Kalleberg K.T., Istre M., Lind A., Lund-Johansen F., Reiakvam O., S&#xf8;raas A.V.L., Harris J.R., Dahl J.A., et al. EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infection. Sci. Rep. 2022;12:11478. doi: 10.1038/s41598-022-15467-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15467-1</ArticleId><ArticleId IdType="pmc">PMC9261254</ArticleId><ArticleId IdType="pubmed">35798818</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X., Li W., Wang T., Ran D., Davalos V., Planas-Serra L., Pujol A., Esteller M., Wang X., Yu H. Accelerated biological aging in COVID-19 patients. Nat. Commun. 2022;13:2135. doi: 10.1038/s41467-022-29801-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29801-8</ArticleId><ArticleId IdType="pmc">PMC9018863</ArticleId><ArticleId IdType="pubmed">35440567</ArticleId></ArticleIdList></Reference><Reference><Citation>Kappelmann N., Dantzer R., Khandaker G.M. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology. 2021;131:105295. doi: 10.1016/j.psyneuen.2021.105295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2021.105295</ArticleId><ArticleId IdType="pmc">PMC8172271</ArticleId><ArticleId IdType="pubmed">34119855</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz I.C., Bertoni A.P.S., Wink M.R. MSC-exosomes carrying MiRNA&#x2014;Could they enhance tocilizumab activity in neuropathology of COVID-19? Stem Cell Rev. Rep. 2023;19:279&#x2013;283. doi: 10.1007/s12015-022-10409-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-022-10409-w</ArticleId><ArticleId IdType="pmc">PMC9261118</ArticleId><ArticleId IdType="pubmed">35794511</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Halim A., Halim M., Liu S., Aljeldah M., Al Shammari B.R., Alwarthan S., Alhajri M., Alawfi A., Alshengeti A., et al. Inflammatory and vascular biomarkers in post-COVID-19 syndrome: A systematic review and meta-analysis of over 20 biomarkers. Rev. Med. Virol. 2023;33:e2424. doi: 10.1002/rmv.2424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2424</ArticleId><ArticleId IdType="pubmed">36708022</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankovic M., Nikolic D., Novakovic I., Petrovic B., Lackovic M., Santric-Milicevic M. MiRNAs as a potential biomarker in the COVID-19 infection and complications course, severity, and outcome. Diagnostics. 2023;13:1091. doi: 10.3390/diagnostics13061091.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13061091</ArticleId><ArticleId IdType="pmc">PMC10047241</ArticleId><ArticleId IdType="pubmed">36980399</ArticleId></ArticleIdList></Reference><Reference><Citation>Parra-Lucares A., Segura P., Rojas V., Pumarino C., Saint-Pierre G., Toro L. Emergence of SARS-CoV-2 variants in the world: How could this happen? Life. 2022;12:194. doi: 10.3390/life12020194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12020194</ArticleId><ArticleId IdType="pmc">PMC8879166</ArticleId><ArticleId IdType="pubmed">35207482</ArticleId></ArticleIdList></Reference><Reference><Citation>Thye A.Y., Law J.W., Pusparajah P., Letchumanan V., Chan K.G., Lee L.H. Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis. Biomedicines. 2021;9:1303. doi: 10.3390/biomedicines9101303.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9101303</ArticleId><ArticleId IdType="pmc">PMC8533361</ArticleId><ArticleId IdType="pubmed">34680420</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Notarte K.I., Peligro P.J., Velasco J.V., Ocampo M.J., Henry B.M., Arendt-Nielsen L., Torres-Macho J., Plaza-Manzano G. Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: A systematic review of the literature. Viruses. 2022;14:2629. doi: 10.3390/v14122629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Du M., Ma Y., Deng J., Liu M., Liu J. Comparison of long COVID-19 caused by different SARS-CoV-2 strains: A systematic review and meta-analysis. Int. J. Environ. Res. Public Health. 2022;19:16010. doi: 10.3390/ijerph192316010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316010</ArticleId><ArticleId IdType="pmc">PMC9736973</ArticleId><ArticleId IdType="pubmed">36498103</ArticleId></ArticleIdList></Reference><Reference><Citation>Medi&#x107; S., Anastassopoulou C., Lozanov-Crvenkovi&#x107; Z., Vukovi&#x107; V., Dragni&#x107; N., Petrovi&#x107; V., Risti&#x107; M., Pustahija T., Gojkovi&#x107; Z., Tsakris A., et al. Risk and severity of SARS-CoV-2 reinfections during 2020&#x2013;2022 in Vojvodina, Serbia: A population-level observational study. Lancet Reg. Health-Eur. 2022;20:100453. doi: 10.1016/j.lanepe.2022.100453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100453</ArticleId><ArticleId IdType="pmc">PMC9246704</ArticleId><ArticleId IdType="pubmed">35791336</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Forecasting Team Past SARS-CoV-2 infection protection against re-infection: A systematic review and meta-analysis. Lancet. 2023;401:833&#x2013;842. doi: 10.1016/S0140-6736(22)02465-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)02465-5</ArticleId><ArticleId IdType="pmc">PMC9998097</ArticleId><ArticleId IdType="pubmed">36930674</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med. 2022;28:2398&#x2013;2405. doi: 10.1038/s41591-022-02051-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Boufidou F., Medi&#x107; S., Lampropoulou V., Siafakas N., Tsakris A., Anastassopoulou C. SARS-CoV-2 reinfections and long COVID in the post-Omicron phase of the pandemic. Int. J. Mol. Sci. 2023;24:12962. doi: 10.3390/ijms241612962.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241612962</ArticleId><ArticleId IdType="pmc">PMC10454552</ArticleId><ArticleId IdType="pubmed">37629143</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M., De Martino M., Palese A., Chiappinotto S., Fonda F., Gerussi V., Sartor A., Curcio F., Grossi P.A., Isola M., et al. Post-COVID-19 syndrome 2 years after the first wave: The role of humoral response, vaccination and reinfection. Open Forum Infect. Dis. 2023;10:ofad364. doi: 10.1093/ofid/ofad364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad364</ArticleId><ArticleId IdType="pmc">PMC10372856</ArticleId><ArticleId IdType="pubmed">37520419</ArticleId></ArticleIdList></Reference><Reference><Citation>Flacco M.E., Acuti Martellucci C., Baccolini V., De Vito C., Renzi E., Villari P., Manzoli L. COVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: Meta-analysis. Front. Med. 2022;9:1023507. doi: 10.3389/fmed.2022.1023507.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1023507</ArticleId><ArticleId IdType="pmc">PMC9681813</ArticleId><ArticleId IdType="pubmed">36438045</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the realworld: A systematic review and meta-analysis. Int. J. Environ. Res. Public Health. 2022;19:12422. doi: 10.3390/ijerph191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A., Iwagami M., Yasuhara J., Takagi H., Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023;41:1783&#x2013;1790. doi: 10.1016/j.vaccine.2023.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Orend&#xe1;&#x10d;ov&#xe1; M., Kva&#x161;&#x148;&#xe1;k E. Effects of vaccination, new SARS-CoV-2 variants and reinfections on post-COVID-19 complications. Front. Public Health. 2022;10:903568. doi: 10.3389/fpubh.2022.903568.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.903568</ArticleId><ArticleId IdType="pmc">PMC9372538</ArticleId><ArticleId IdType="pubmed">35968477</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>